SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-117691
Filing Date
2016-08-09
Accepted
2016-08-09 16:12:01
Documents
85
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v445715_10q.htm 10-Q 761230
2 EXHIBIT 31.1 v445715_ex31-1.htm EX-31.1 11231
3 EXHIBIT 31.2 v445715_ex31-2.htm EX-31.2 10669
4 EXHIBIT 32.1 v445715_ex32-1.htm EX-32.1 5008
5 EXHIBIT 32.2 v445715_ex32-2.htm EX-32.2 5434
  Complete submission text file 0001144204-16-117691.txt   5611302

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eltp-20160630.xml EX-101.INS 1231790
7 XBRL TAXONOMY EXTENSION SCHEMA eltp-20160630.xsd EX-101.SCH 59224
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eltp-20160630_cal.xml EX-101.CAL 38572
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eltp-20160630_def.xml EX-101.DEF 332703
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltp-20160630_lab.xml EX-101.LAB 399821
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltp-20160630_pre.xml EX-101.PRE 388677
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 161818032
SIC: 2834 Pharmaceutical Preparations